 Given the abovementioned advantages of ketorolac, and the particular propensity for abdominally based free flap BR patients to be negatively affected by narcotic side effects, we hypothesize that the addition of ketorolac to a routine multimodal postoperative analgesia regimen will reduce hospital stay by a day or more. 